|GILD -- USA Stock|| |
USD 73.27 0.93 1.29%
retains regular Real Value
of $83.6525 per share. The prevalent price of the corporation is $73.27. At this time the corporation appears to be under valued
. Macroaxis calculates value of Gilead Sciences
from evaluating the corporation fundamentals
such as Current Valuation
of 100.05B, Return On Asset
of 10.77% and Return On Equity of 9.97% as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage to acquire undervalued assets and to sell overvalued assets since at some point stocks prices and their ongoing real values will come together.
Gilead Science took a bad hit when their bet on a medical trial failed. Subsequently, their stock price has come down considerably. But, the company is still profitable and is very focused on growth ahead. Also, market forces should easily push the stock price higher than where it is when looked at from a price-to-earnings ratio. For that matter, by any matrix, the stock is cheap and should go higher.
Valuation Drivers Correlation
Net Income Per Employee Enterprise Value Market Capitalization
Gilead Sciences Valuation Data Drivers
Gilead Sciences Market Cap
Gilead Sciences is one of the top stocks in market capitalization category among related companies. Market capitalization
industry is currently estimated at about 103.16 Billion. Gilead Sciences totals roughly 96.15 Billion in market capitalization claiming about 93% of stocks in Biotechnology industry.